Project Grant R01DA061952
Award Date
9/1/24
Completion Date
5/31/29
Dollars Obligated
$2.9M
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $157,568 to Drexel University to elucidate corticolimbic circuit and neuroimmune mechanisms underlying HIV-induced dysregulation of reward-seeking behavior. The research aims to use optogenetic and chemogenetic techniques to stimulate the infralimbic cortex-nucleus accumbens shell circuit and modulate microglial function to rescue HIV-induced...
This federal Project Grant award of $162,486 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to understand the effects of concurrent chronic stress and cocaine self-administration on microglia activity and dendritic spine morphology in the medial prefrontal cortex, and how these changes influence drug-seeking behavior. The award, with a start date of December 3, 2024 and an ultimate completion date of April 30,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the NIH's Drug Use and Addiction Research Programs (CFDA 93.279), will fund a $751,043 research project at the University of Massachusetts Medical School focused on investigating the cellular and molecular mechanisms underlying the complex co-morbidity of opioid use disorder (OUD), major depressive disorder (MDD), and HIV in the human brain. The project will leverage single-cell sequencing technologies and other...
This federal Project Grant award of $3,580,802, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to study the stress-immune mechanisms in people living with HIV (PLWH) who also have cannabis use disorder (CUD) and major depressive disorder (MDD). The research will: Determine the hypothalamic-pituitary-adrenal (HPA) and immune response to acute stress among healthy controls, PLWH, and PLWH with CUD and MDD. Identify...
The National Institute on Drug Abuse (NIDA) awarded a $2,223,769 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of California, San Diego (UCSD) to investigate the individual and combined impact of HIV and opioids on inflammasome-mediated neuroinflammation and neurotoxicity. The 5-year study, which commenced on April 15, 2025, aims to uncover the mechanistic intersection between HIV and opioids that leads to more severe neurological...
This Project Grant award from the National Institute on Drug Abuse (NIDA), with the official CFDA program title "Drug Use and Addiction Research Programs", is funding the development of an educational intervention to train a diverse workforce in addiction data science. The $136,320 award will support the creation of an immersive, tailored addiction data science skills course that provides hands-on training in areas such as FAIR data principles, computational analytics, and natural...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $148,568 to investigate the mechanisms of dopamine transmission and its role in reward-related behaviors. The award period runs from January 1, 2025 to July 31, 2027. The funded research aims to advance the mechanistic understanding of how dopamine signaling occurs at the subcellular level, given limitations in prior methodologies. The...
This Project Grant award, valued at $695,250.00 and awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the role of endothelial injury and myeloid cell migration in the activation of inflammasomes in HIV infection and cocaine exposure. The key objectives are to characterize myeloid cell populations in the brains of HIV-transgenic mice under chronic cocaine treatment, and evaluate the...
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), has awarded a $1,372,480 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Board of Regents of the University of Nebraska's University of Nebraska Medical Center (UNMC) division. The 5-year grant, effective April 15, 2025 through January 31, 2030, will fund research to elucidate the molecular mechanisms by which the interplay of HIV transactivator of transcription...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support research to explore the unique neurobehavioral profile of sequential opioid-stimulant polysubstance use disorders. The $314,225 award, effective July 31, 2024 through February 28, 2025, will fund a study conducted by the University of Washington to: 1) Define the behavioral profile of dual opioid-methamphetamine use disorders in a...